查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1786631

全球胃腸道藥物輸送系統外包市場

Gastroretentive Drug Delivery Systems Outsourcing
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2030年全球胃腸道藥物輸送系統外包市場規模將達20億美元

全球胃腸道藥物輸送系統外包市場規模預計在2024年達到15億美元，預計2024年至2030年期間的複合年成長率為5.2%，到2030年將達到20億美元。錠劑劑型是本報告分析的細分市場之一，預計其複合年成長率為3.8%，到分析期結束時規模將達到6.17億美元。液體劑型細分市場在分析期間的複合年成長率預計為6.9%。

美國市場規模估計為 4.025 億美元，中國市場預期複合年成長率為 8.0%

美國胃腸道藥物輸送系統外包市場規模預計在2024年達到4.025億美元。作為世界第二大經濟體，中國市場規模預計在2030年達到3.942億美元，2024年至2030年的複合年成長率為8.0%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間的複合年成長率分別為2.6%和5.1%。在歐洲，預計德國市場的複合年成長率為3.3%。

全球胃腸道藥物輸送系統外包市場—主要趨勢與促進因素摘要

隨著製藥公司尋求提高吸收窗口窄或上消化道溶解度有限的藥物的生物生物有效性和療效，外包胃滯留藥物遞送系統 (GRDDS) 已受到廣泛關注。 GRDDS 技術，包括漂浮系統、生物黏附系統、膨脹系統和緻密系統，高度專業化，需要豐富的配方專業知識和先進的基礎設施。因此，許多藥物開發商選擇與擁有技術力和監管專業知識的合約開發和受託製造廠商(CDMO) 合作，以便有效地將這些複雜的製劑推向市場。

影響GRDDS外包市場的關鍵趨勢包括：對緩釋性口服製劑日益成長的需求、對以患者為中心的藥物輸送的日益重視，以及在競爭環境中實現產品差異化的需求。 GRDDS的採用對於治療慢性胃腸道疾病、心血管疾病和第2型糖尿病的藥物尤其重要，因為延長藥物的停留時間可以增強療效。隨著大型製藥企業精簡內部業務以專注於核心研發，將GRDDS製劑配方、規模化生產和生產等非核心業務外包已成為一項策略要務。此外，監管機構對藥物釋放特性一致性的期望以及對生命週期管理的日益重視，也推動了該領域對專業合作夥伴的需求。

為什麼 GRDDS 在技術上要求很高且值得外包？

胃滯留藥物傳遞系統本身就很複雜，需要先進的技術來精確控制藥物在胃中的釋放動力學、浮力、黏度和膨脹。這些要求對配方設計、輔料選擇以及即時體內外相關性測試提出了很高的要求。中小型製藥公司，尤其是處於早期研發階段的公司，通常缺乏獨立開發此類系統的內部基礎設施。外包可以提供先進的分析工具、GRDDS 專用輔料庫以及中試規模的生產設施，且無需承擔資金負擔。

另一個主要因素是人們對聚合物科學的興趣日益濃厚，新型生物黏附聚合物和水凝膠正在開發中，以改善胃內滯留和藥物吸收。擁有材料科學和控制釋放平台專業知識的CDMO如今是縮短GRDDS藥物上市時間的關鍵盟友。另一個好處是，口服生技藥品和胜肽類藥物的需求日益成長，這些藥物通常在腸道中分解，並受益於上消化道的吸收，促使製劑設計師尋求GRDDS途徑。許多製藥公司內部很少具備此類利基能力，因此外包合作夥伴成為應對這些新興製劑挑戰的關鍵推動者。

哪些治療領域和最終用途趨勢正在影響需求？

GRDDS 的治療應用正在超越傳統的胃腸道健康領域。雖然消化性潰瘍、幽門螺旋桿菌根除和胃食道逆流症 (GERD) 仍是其主要應用領域，但 GRDDS 在代謝紊亂、帕金森氏症以及需要在胃內進行特異性給藥的感染疾病治療中的應用已顯著增加。溶解度依賴 pH 或在腸液中穩定性較差的藥物尤其適合 GRDDS，這使得這種方法對於現有分子的重新配方策略和生命週期延長具有吸引力。

製藥公司尋求應對人口老化並提高患者依從性也推動了外包需求。 GRDDS 技術可以降低給藥頻率並改善藥物動力學特徵，這對於慢性病治療至關重要。對於兒科和老年藥物輸送，漂浮和黏膜黏附 GRDDS 可以改善藥物釋放和停留時間的控制，從而解決吞嚥性和劑量均勻性方面的問題。我們積極尋求在易用口服劑型方面擁有豐富經驗、並針對這些特定人群提供監管文件支持的主要企業來主導開發計劃。

推動全球 GRDDS 外包成長的因素有哪些？

胃腸道藥物遞送系統外包市場的成長受到多種因素的推動，包括需要標靶遞送至上消化道的藥物分子日益複雜、慢性胃病和代謝疾病的盛行率不斷上升，以及受益於生物有效性的藥物產品線不斷擴大。不斷發展的製藥研發格局，包括對生命週期管理和複方藥物製劑日益成長的興趣，為 GRDDS 技術提供了肥沃的土壤。外包使公司能夠利用 CDMO 提供的專業知識庫、專有遞送平台和快速擴展流程。

智慧聚合物、漂浮製劑氣體生成系統以及先進的胃滯留錠劑3D列印等技術創新，正在進一步提升委託合作夥伴的能力。此外，關於符合GRDDS標準的產品的監管清晰性以及全球對品質源於設計 (QbD) 的重視，正鼓勵與專業外包供應商進行早期合作。印度和東歐等新興市場CDMO服務的擴張也推動了外包趨勢，因為不斷成長的科學專業知識與成本優勢相輔相成。隨著製藥公司不斷追求產品開發的敏捷性、創新性和速度，GRDDS外包仍將是整個藥物開發價值鏈的策略重點領域。

部分

劑型（錠劑、液體、微球、膠囊、其他劑型）

受訪公司範例

  • Adare Pharma Solutions
  • Aenova Group
  • Almac Group
  • Aptar Pharma
  • Ashland Global Holdings Inc.
  • Catalent, Inc.
  • Colorcon, Inc.
  • Convatec Group
  • CordenPharma International
  • Evonik Industries AG
  • Evotec SE
  • Halozyme Therapeutics
  • Lonza Group AG
  • Patheon（Thermo Fisher Scientific）
  • Pharmaron Beijing Co., Ltd.
  • Quotient Sciences
  • Recipharm AB
  • Rubicon Research Pvt. Ltd.
  • Siegfried Holding AG
  • Vectura Group Ltd.

人工智慧整合

我們正在利用有效的專家內容和人工智慧工具來改變市場和競爭情報。

Global 特定產業產業SLM 的典型規範，而是建立了一個從世界各地專家收集的內容庫，包括影片錄影、部落格、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地和進出口（成品和原始設備製造商）情況預測其競爭地位的變化。這種複雜而多面的市場動態預計將以多種方式影響競爭對手，包括銷貨成本(COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 競賽

簡介目錄
Product Code: MCP31156

Global Gastroretentive Drug Delivery Systems Outsourcing Market to Reach US$2.0 Billion by 2030

The global market for Gastroretentive Drug Delivery Systems Outsourcing estimated at US$1.5 Billion in the year 2024, is expected to reach US$2.0 Billion by 2030, growing at a CAGR of 5.2% over the analysis period 2024-2030. Tablets Dosage Form, one of the segments analyzed in the report, is expected to record a 3.8% CAGR and reach US$617.0 Million by the end of the analysis period. Growth in the Liquid Dosage Form segment is estimated at 6.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$402.5 Million While China is Forecast to Grow at 8.0% CAGR

The Gastroretentive Drug Delivery Systems Outsourcing market in the U.S. is estimated at US$402.5 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$394.2 Million by the year 2030 trailing a CAGR of 8.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.6% and 5.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.3% CAGR.

Global Gastroretentive Drug Delivery Systems Outsourcing Market - Key Trends & Drivers Summarized

The outsourcing of gastroretentive drug delivery systems (GRDDS) is gaining significant traction as pharmaceutical companies seek to improve bioavailability and therapeutic efficacy of drugs with narrow absorption windows or limited solubility in the upper gastrointestinal (GI) tract. GRDDS technologies such as floating systems, bioadhesive systems, swelling and expanding systems, and high-density systems are highly specialized and require extensive formulation expertise and advanced infrastructure. As a result, many drug developers are partnering with contract development and manufacturing organizations (CDMOs) that possess the technical capabilities and regulatory know-how to bring these complex formulations to market efficiently.

Key trends influencing the GRDDS outsourcing market include rising demand for extended-release oral formulations, increasing focus on patient-centric drug delivery, and the need to differentiate products in a competitive therapeutic landscape. The adoption of GRDDS is particularly valuable for drugs treating chronic gastrointestinal disorders, cardiovascular diseases, and type 2 diabetes, where prolonged drug residence time enhances therapeutic outcomes. As major pharmaceutical firms streamline internal operations to focus on core R&D, outsourcing non-core competencies such as GRDDS formulation, scale-up, and manufacturing has become a strategic imperative. Furthermore, regulatory expectations for consistency in drug release profiles and the growing emphasis on lifecycle management are also driving the need for specialized partners in this space.

What Makes GRDDS So Technically Demanding - And Attractive to Outsource?

Gastroretentive drug delivery systems are inherently complex, involving advanced technologies that must ensure precise control over drug release kinetics, buoyancy, adhesion, or expansion in the stomach. These requirements place significant demands on formulation design, choice of excipients, and real-time in vitro/in vivo correlation testing. Small and mid-sized pharmaceutical companies often lack the in-house infrastructure to develop such systems independently, especially for early-phase development. Outsourcing allows them access to advanced analytical tools, GRDDS-specific excipient libraries, and pilot-scale production facilities without the capital burden.

Another major factor is the growing interest in polymer science, where novel bioadhesive polymers and hydrogels are being developed to improve gastric retention and drug absorption. CDMOs with expertise in material science and controlled-release platforms are now critical collaborators in accelerating time-to-market for GRDDS-enabled drugs. Additionally, the increasing demand for oral biologics and peptides, which often degrade in the intestines and benefit from upper GI absorption, is pushing formulators to seek GRDDS routes. This niche capability is rarely available in-house for many pharmaceutical firms, positioning outsourcing partners as key enablers in addressing these emerging formulation challenges.

Which Therapeutic Areas and End-Use Trends Are Shaping the Demand?

Therapeutic applications of GRDDS are expanding beyond the traditional focus areas of gastrointestinal health. While peptic ulcers, Helicobacter pylori eradication, and gastroesophageal reflux disease (GERD) still dominate usage, there is a marked rise in the application of GRDDS in the management of metabolic disorders, Parkinson’s disease, and infectious diseases requiring site-specific drug delivery in the stomach. Drugs with pH-dependent solubility or poor stability in intestinal fluids are particularly well-suited to GRDDS, making this approach attractive for reformulation strategies and lifecycle extension of existing molecules.

Outsourcing demand is also being driven by pharmaceutical companies aiming to serve aging populations and improve patient adherence. GRDDS technologies enable reduced dosing frequency and enhanced pharmacokinetic profiles, which are essential in chronic therapies. In pediatric and geriatric drug delivery, floating and mucoadhesive GRDDS offer better control over drug release and residence time, addressing swallowability and dose uniformity concerns. Outsourcing companies with a strong background in user-friendly oral dosage forms and regulatory dossier support for these specific populations are being actively sought out to lead development projects.

What’s Fueling the Growth in GRDDS Outsourcing Across the Globe?

The growth in the gastroretentive drug delivery systems outsourcing market is driven by several factors, including the rising complexity of drug molecules requiring targeted delivery in the upper GI tract, the increasing prevalence of chronic gastric and metabolic diseases, and a growing pipeline of drugs that benefit from enhanced bioavailability. The evolving pharmaceutical R&D landscape-with heightened focus on lifecycle management and fixed-dose combinations-has created a fertile ground for GRDDS technologies. Outsourcing enables companies to tap into specialized knowledge bases, proprietary delivery platforms, and faster scale-up processes offered by CDMOs.

Technological innovations such as smart polymers, gas-generating systems for floating formulations, and advanced 3D printing of gastroretentive tablets are further enhancing the capabilities of outsourced development partners. Additionally, regulatory clarity around GRDDS-enabled products and a strong global emphasis on quality-by-design (QbD) are encouraging early engagement with expert outsourcing providers. The expansion of CDMO services in emerging markets like India and Eastern Europe-where cost advantages are complemented by growing scientific expertise-is also fueling the outsourcing trend. As pharmaceutical companies continue to seek agility, innovation, and speed in product development, GRDDS outsourcing is set to remain a strategic focus area across the drug development value chain.

SCOPE OF STUDY:

The report analyzes the Gastroretentive Drug Delivery Systems Outsourcing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Dosage Form (Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form, Other Dosage Forms)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

  • Adare Pharma Solutions
  • Aenova Group
  • Almac Group
  • Aptar Pharma
  • Ashland Global Holdings Inc.
  • Catalent, Inc.
  • Colorcon, Inc.
  • Convatec Group
  • CordenPharma International
  • Evonik Industries AG
  • Evotec SE
  • Halozyme Therapeutics
  • Lonza Group AG
  • Patheon (Thermo Fisher Scientific)
  • Pharmaron Beijing Co., Ltd.
  • Quotient Sciences
  • Recipharm AB
  • Rubicon Research Pvt. Ltd.
  • Siegfried Holding AG
  • Vectura Group Ltd.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Gastroretentive Drug Delivery Systems Outsourcing - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Complexity of GRDDS Formulations Spurs Demand for Specialized Outsourcing Partners
    • Pharma Industry Focus on Core R&D and Cost Reduction Accelerates Outsourcing of Gastroretentive Drug Development
    • Growing Number of Emerging Biopharma and Virtual Drug Companies Increases Outsourcing Demand for GRDDS
    • CMOs and CDMOs Expanding Capabilities in Mucoadhesive, Floating, and Swellable GRDDS Boost Outsourcing Opportunities
    • Need for Specialized Equipment and Regulatory Expertise Drives Contract Manufacturing of GRDDS Technologies
    • OEM Investments in Dedicated Oral Solid Dosage Lines Enhance Service Offering for Gastroretentive Formulations
    • Growth in Modified Release and Site-Specific Delivery Markets Creates Outsourcing Opportunities for Niche CDMOs
    • Increased FDA and EMA Regulatory Stringency Spurs Demand for GRDDS Outsourcing to Compliant Facilities
    • Collaborative GRDDS Development Models Between Innovators and CMOs Strengthen Speed-to-Market Advantage
    • Focus on Small Batch, High-Potency Drug Formulation Supports Outsourcing of Clinical-Stage GRDDS Projects
    • Rising Demand for Analytical and Bioavailability Testing Capabilities Expands Scope of GRDDS Outsourcing
    • Contract Development Partners Offering 3D Printing and Novel Dosage Platforms Gain Competitive Edge in GRDDS Market
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Gastroretentive Drug Delivery Systems Outsourcing Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems Outsourcing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Gastroretentive Drug Delivery Systems Outsourcing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Gastroretentive Drug Delivery Systems Outsourcing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Tablets Dosage Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Tablets Dosage Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Tablets Dosage Form by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Liquid Dosage Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Liquid Dosage Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Liquid Dosage Form by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Microspheres Dosage Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Microspheres Dosage Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Microspheres Dosage Form by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Capsule Dosage Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Capsule Dosage Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Capsule Dosage Form by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other Dosage Forms by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other Dosage Forms by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Other Dosage Forms by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Gastroretentive Drug Delivery Systems Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: USA 15-Year Perspective for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Percentage Breakdown of Value Sales for Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 23: Canada Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: Canada Historic Review for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: Canada 15-Year Perspective for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Percentage Breakdown of Value Sales for Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms for the Years 2015, 2025 & 2030
  • JAPAN
    • Gastroretentive Drug Delivery Systems Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 26: Japan Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Japan Historic Review for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: Japan 15-Year Perspective for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Percentage Breakdown of Value Sales for Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms for the Years 2015, 2025 & 2030
  • CHINA
    • Gastroretentive Drug Delivery Systems Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 29: China Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: China Historic Review for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: China 15-Year Perspective for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Percentage Breakdown of Value Sales for Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms for the Years 2015, 2025 & 2030
  • EUROPE
    • Gastroretentive Drug Delivery Systems Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 32: Europe Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems Outsourcing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 33: Europe Historic Review for Gastroretentive Drug Delivery Systems Outsourcing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: Europe 15-Year Perspective for Gastroretentive Drug Delivery Systems Outsourcing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 35: Europe Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Europe Historic Review for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Europe 15-Year Perspective for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Percentage Breakdown of Value Sales for Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms for the Years 2015, 2025 & 2030
  • FRANCE
    • Gastroretentive Drug Delivery Systems Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 38: France Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: France Historic Review for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: France 15-Year Perspective for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Percentage Breakdown of Value Sales for Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms for the Years 2015, 2025 & 2030
  • GERMANY
    • Gastroretentive Drug Delivery Systems Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 41: Germany Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Germany Historic Review for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Germany 15-Year Perspective for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Percentage Breakdown of Value Sales for Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 44: Italy Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Italy Historic Review for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Italy 15-Year Perspective for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Percentage Breakdown of Value Sales for Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Gastroretentive Drug Delivery Systems Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 47: UK Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: UK Historic Review for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: UK 15-Year Perspective for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Percentage Breakdown of Value Sales for Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 50: Spain Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Spain Historic Review for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Spain 15-Year Perspective for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Percentage Breakdown of Value Sales for Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 53: Russia Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Russia Historic Review for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Russia 15-Year Perspective for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Percentage Breakdown of Value Sales for Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 56: Rest of Europe Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Rest of Europe Historic Review for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Rest of Europe 15-Year Perspective for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Percentage Breakdown of Value Sales for Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Gastroretentive Drug Delivery Systems Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 59: Asia-Pacific Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems Outsourcing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 60: Asia-Pacific Historic Review for Gastroretentive Drug Delivery Systems Outsourcing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Asia-Pacific 15-Year Perspective for Gastroretentive Drug Delivery Systems Outsourcing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 62: Asia-Pacific Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Asia-Pacific Historic Review for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Asia-Pacific 15-Year Perspective for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Percentage Breakdown of Value Sales for Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Gastroretentive Drug Delivery Systems Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 65: Australia Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Australia Historic Review for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Australia 15-Year Perspective for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Percentage Breakdown of Value Sales for Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms for the Years 2015, 2025 & 2030
  • INDIA
    • Gastroretentive Drug Delivery Systems Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 68: India Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: India Historic Review for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: India 15-Year Perspective for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Percentage Breakdown of Value Sales for Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 71: South Korea Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: South Korea Historic Review for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: South Korea 15-Year Perspective for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Percentage Breakdown of Value Sales for Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 74: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Rest of Asia-Pacific Historic Review for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Rest of Asia-Pacific 15-Year Perspective for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Percentage Breakdown of Value Sales for Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Gastroretentive Drug Delivery Systems Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 77: Latin America Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems Outsourcing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 78: Latin America Historic Review for Gastroretentive Drug Delivery Systems Outsourcing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Latin America 15-Year Perspective for Gastroretentive Drug Delivery Systems Outsourcing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 80: Latin America Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Latin America Historic Review for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Latin America 15-Year Perspective for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Percentage Breakdown of Value Sales for Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 83: Argentina Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Argentina Historic Review for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Argentina 15-Year Perspective for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Percentage Breakdown of Value Sales for Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 86: Brazil Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Brazil Historic Review for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Brazil 15-Year Perspective for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Percentage Breakdown of Value Sales for Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 89: Mexico Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Mexico Historic Review for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Mexico 15-Year Perspective for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Percentage Breakdown of Value Sales for Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 92: Rest of Latin America Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Latin America Historic Review for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Latin America 15-Year Perspective for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Percentage Breakdown of Value Sales for Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Gastroretentive Drug Delivery Systems Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 95: Middle East Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems Outsourcing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 96: Middle East Historic Review for Gastroretentive Drug Delivery Systems Outsourcing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Middle East 15-Year Perspective for Gastroretentive Drug Delivery Systems Outsourcing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 98: Middle East Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Middle East Historic Review for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Middle East 15-Year Perspective for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Percentage Breakdown of Value Sales for Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 101: Iran Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Iran Historic Review for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Iran 15-Year Perspective for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Percentage Breakdown of Value Sales for Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 104: Israel Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Israel Historic Review for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Israel 15-Year Perspective for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Percentage Breakdown of Value Sales for Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 107: Saudi Arabia Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Saudi Arabia Historic Review for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Saudi Arabia 15-Year Perspective for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Percentage Breakdown of Value Sales for Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 110: UAE Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UAE Historic Review for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: UAE 15-Year Perspective for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Percentage Breakdown of Value Sales for Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 113: Rest of Middle East Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Rest of Middle East Historic Review for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Rest of Middle East 15-Year Perspective for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Percentage Breakdown of Value Sales for Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms for the Years 2015, 2025 & 2030
  • AFRICA
    • Gastroretentive Drug Delivery Systems Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 116: Africa Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Africa Historic Review for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: Africa 15-Year Perspective for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Percentage Breakdown of Value Sales for Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms for the Years 2015, 2025 & 2030

IV. COMPETITION